D’Annibale, O.M.; Phua, Y.L.; Van’t Land, C.; Karunanidhi, A.; Dorenbaum, A.; Mohsen, A.-W.; Vockley, J.
Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular Bioenergetics. Cells 2022, 11, 2635.
https://doi.org/10.3390/cells11172635
AMA Style
D’Annibale OM, Phua YL, Van’t Land C, Karunanidhi A, Dorenbaum A, Mohsen A-W, Vockley J.
Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular Bioenergetics. Cells. 2022; 11(17):2635.
https://doi.org/10.3390/cells11172635
Chicago/Turabian Style
D’Annibale, Olivia M., Yu Leng Phua, Clinton Van’t Land, Anuradha Karunanidhi, Alejandro Dorenbaum, Al-Walid Mohsen, and Jerry Vockley.
2022. "Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular Bioenergetics" Cells 11, no. 17: 2635.
https://doi.org/10.3390/cells11172635
APA Style
D’Annibale, O. M., Phua, Y. L., Van’t Land, C., Karunanidhi, A., Dorenbaum, A., Mohsen, A.-W., & Vockley, J.
(2022). Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular Bioenergetics. Cells, 11(17), 2635.
https://doi.org/10.3390/cells11172635